| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945320 | European Journal of Surgical Oncology (EJSO) | 2018 | 26 Pages |
Abstract
Treatment with CRS and HIPEC for biliary carcinoma with peritoneal metastasis is feasible and may provide survival benefit when compared to palliative chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
I. Amblard, F. Mercier, D.L. Bartlett, S.A. Ahrendt, K.W. Lee, H.J. Zeh, E.A. Levine, D. Baratti, M. Deraco, P. Piso, D.L. Morris, B. Rau, A.A.K. Tentes, J.-J. Tuech, F. Quenet, E. Akaishi, M. Pocard, Y. Yonemura, H.J. Zeh,